Skip to main content
    M

    Moleculin Biotech Inc (MBRX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.14
    -0.73 (-9.28%)

    Market Cap: $8.02M

    Last updated: Nov 17, 2026 at 10:59 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    51%(19/37)
    Avg Surprise
    +5.90%
    Streak
    2 Q

    Upcoming Estimates

    Reports Mar 16, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$8.70
    Range-$9.21 - -$8.40
    5 analysts
    Revenue Consensus
    N/A
    RangeN/A
    5 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-1372.00%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio1.37xQuick Ratio1.37x
    Trading Statistics
    Beta2.09Avg Volume90.95K
    52-Week High$227.0552-Week Low$3.23

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 27.1% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 38.6, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$8.21
    SMA 20$7.85
    SMA 50$9.80
    SMA 200$35.92
    EMA 10$7.98
    EMA 20$8.16
    EMA 50$10.83
    EMA 200$53.83

    MACD

    Line: -0.42Signal: -0.52Hist: 0.10

    ADX

    ADX: 55.4+DI: 8.7-DI: 4.7

    Aroon & PSAR

    Aroon Up48.0
    Aroon Down20.0
    PSAR$9.96

    Bollinger Bands

    Upper Band$9.83
    Lower Band$5.87
    %B Position5034%(Upper)
    Band Width0.32

    RSI (14-Day)

    Neutral
    38.6

    Momentum Oscillators

    Stoch %K22.6
    Stoch %D37.3
    Williams %R-96.6
    ROC (10d)-14.2%
    Momentum-1.18
    CCI (20d)-41.6
    MFI (14d)58.2

    Volatility Measures

    ATR (14d)$2.91(40.8%)
    StdDev (20d)0.99
    Hist Vol150.0%(High)

    Volume Flow

    VWAP$7.30
    OBV122.5M
    AD Line4560.1B
    CMF (20d)0.181

    Volume Metrics

    Avg Vol (20d)42.2K
    Vol Ratio0.4x(Low)
    VWMA (20d)$7.86

    Pivot Points

    R3$8.47
    R2$8.28
    R1$8.08
    Pivot Point$7.89
    S1$7.69
    S2$7.50
    S3$7.30

    Advanced Oscillators

    TSI-11.16
    Ultimate Osc35.0
    KST-27.45

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about MBRX

    News

    MBRX Valuation

    GNG's valuation label for MBRX is Undervalued.

    P/B
    0.4x
    All MBRX metrics

    MBRX Profitability: Margins, ROIC and FCF

    Moleculin Biotech (MBRX) has an operating margin of 0.0% and a net margin of 0.0%.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -1372.0%
    MBRX financial statements

    Moleculin Biotech Competitors

    The companies most similar to Moleculin Biotech (MBRX) include Marker Therapeutics, GT Biopharma and Tempest Therapeutics.

    Sector: Healthcare

    Companies most similar to Moleculin Biotech

    MBRX Analyst Ratings

    Moleculin Biotech (MBRX) has a Buy consensus from 3 analysts: 3 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    3
    Strong Buy
    1
    Buy
    2
    Hold
    0
    Sell
    0
    Strong Sell
    0
    MBRX stock forecast

    MBRX Earnings: Beat Rate and Next Report

    Moleculin Biotech (MBRX) beat the EPS estimate in 5 of the last 8 quarters (62.5%). Its next report is expected on Mar 16, 2027.

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    13.0%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$8.70
    MBRX earnings history

    MBRX Earnings Date

    MBRX reports Mar 16, 2027. The date is estimated.

    MBRX Earnings Call

    The latest MBRX earnings call transcript on file is labeled 2025Q1.

    Read the 2025Q1 transcript

    MBRX ETF Holders

    See insider activity

    Updated Nov 13, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About MBRX

    When does MBRX report earnings?

    Moleculin Biotech Inc (MBRX) is expected to report earnings on Mar 16, 2027.

    Does MBRX pay dividends?

    Moleculin Biotech Inc (MBRX) does not currently pay a regular dividend.

    What is MBRX's market cap?

    Moleculin Biotech Inc (MBRX) has a market capitalization of $8.02M with a current stock price of $7.14.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.